You are here
- Home
- Drug Products
- All Drug Products
Prevalence of osteoporosis in Korean prostate cancer patients who is reciving LHRH agonist and/or anti-androgen agent
- Disease
- prostate cancer
- Drug Name
- Casodex
- Generic Name
- bicalutamide
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- Non-Interventional Study
- Start Date
- Nov 13, 2009
- Study Name
- NIS-OKR-CAS-2009/1
- Study Id
- NIS-OKR-CAS-2009/1
- ClinicalTrials.gov ID
- NCT01025479
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report
-
Sep 13, 2010
- NIS-OKR-CAS-2009/1.pdf (145 KB)
